Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease




Neurology Minute show

Summary: Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.